1. Home
  2. CNTX vs DSWL Comparison

CNTX vs DSWL Comparison

Compare CNTX & DSWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • DSWL
  • Stock Information
  • Founded
  • CNTX 2015
  • DSWL 1987
  • Country
  • CNTX United States
  • DSWL Macau
  • Employees
  • CNTX N/A
  • DSWL N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • DSWL Plastic Products
  • Sector
  • CNTX Health Care
  • DSWL Industrials
  • Exchange
  • CNTX Nasdaq
  • DSWL Nasdaq
  • Market Cap
  • CNTX 75.6M
  • DSWL 64.2M
  • IPO Year
  • CNTX 2021
  • DSWL 1995
  • Fundamental
  • Price
  • CNTX $1.13
  • DSWL $3.85
  • Analyst Decision
  • CNTX Strong Buy
  • DSWL
  • Analyst Count
  • CNTX 7
  • DSWL 0
  • Target Price
  • CNTX $5.20
  • DSWL N/A
  • AVG Volume (30 Days)
  • CNTX 260.4K
  • DSWL 23.6K
  • Earning Date
  • CNTX 11-05-2025
  • DSWL 11-14-2025
  • Dividend Yield
  • CNTX N/A
  • DSWL 5.14%
  • EPS Growth
  • CNTX N/A
  • DSWL 45.62
  • EPS
  • CNTX N/A
  • DSWL 0.70
  • Revenue
  • CNTX N/A
  • DSWL $67,610,000.00
  • Revenue This Year
  • CNTX N/A
  • DSWL N/A
  • Revenue Next Year
  • CNTX N/A
  • DSWL N/A
  • P/E Ratio
  • CNTX N/A
  • DSWL $5.68
  • Revenue Growth
  • CNTX N/A
  • DSWL N/A
  • 52 Week Low
  • CNTX $0.49
  • DSWL $1.93
  • 52 Week High
  • CNTX $2.59
  • DSWL $4.48
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 69.12
  • DSWL 46.04
  • Support Level
  • CNTX $0.98
  • DSWL $3.83
  • Resistance Level
  • CNTX $1.29
  • DSWL $4.06
  • Average True Range (ATR)
  • CNTX 0.09
  • DSWL 0.10
  • MACD
  • CNTX 0.02
  • DSWL -0.04
  • Stochastic Oscillator
  • CNTX 65.91
  • DSWL 10.72

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

Share on Social Networks: